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64-Detector Row Coronary Computed Tomographic Angiography
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Augustin J. Delago, MD,§ Tracy Q. Callister, MD, Daniel S. Berman, MD,‡ James K. Min, MD‡
New York and Albany, New York; Atlanta, Georgia; Los Angeles, California; and Hendersonville, Tennessee
Objectives We examined mortality risk in relation to extent and composition of nonobstructive plaques by 64-detector row
coronary computed tomographic angiography (CCTA).
Background The prognostic significance of nonobstructive coronary artery plaques by CCTA is poorly understood.
Methods We prospectively evaluated consecutive adults from 2 centers undergoing 64-detector row CCTA without prior
documented coronary artery disease (CAD) and without obstructive (50%) CAD by CCTA. Luminal diameter ste-
nosis severity was classified for each segment as none (0%) or mild (1% to 49%), and plaque composition was
classified as noncalcified, calcified, or mixed.
Results During 3.1  0.5 years, 54 intermediate-term (90 days) deaths occurred among 2,583 patients (2.09%), with
4 early (90 days) deaths. Adjusted for CAD risk factors, the presence of any nonobstructive plaque was associ-
ated with higher mortality (hazard ratio [HR]: 1.98, 95% confidence Interval [CI]: 1.06 to 3.69, p  0.03), with
the highest risk among those exhibiting nonobstructive CAD in 3 epicardial vessels (HR: 4.75, 95% CI: 2.10 to
10.75, p  0.0002) or 5 segments (HR: 5.12, 95% CI: 2.16 to 12.10, p  0.0002). Higher mortality for nonob-
structive CAD was observed even among patients with low 10-year Framingham risk (3.4%, p  0.0001) as well
as those with no traditional, medically treatable CAD risk factors, including diabetes mellitus, hypertension, and
dyslipidemia (6.7%, p  0.0001). No independent relationship between plaque composition and incident mortal-
ity was observed. Importantly, patients without evident plaque experienced a low rate of incident death during
follow-up (0.34%/year).
Conclusions The presence and extent of nonobstructive plaques augment prediction of incident mortality beyond conven-
tional clinical risk assessment. (J Am Coll Cardiol 2011;58:510–9) © 2011 by the American College of Cardiol-
ogy Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.11.078Coronary computed tomographic angiography (CCTA) has
emerged as an accurate noninvasive anatomic imaging modal-
ity for the detection and exclusion of obstructive coronary
artery disease (CAD) (1–3). Early reports have revealed that
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California; §Capital Cardiology Associates, Albany, New York; and the Tennessee
eart and Vascular Institute, Hendersonville, Tennessee. Drs. Delgado and Callister
ave served on the Speakers’ Bureau for GE Healthcare. Dr. Berman has received
esearch support from Lantheus, Astellas Healthcare, GE/Amersham, and Siemens.
r. Min has served on the Speakers’ Bureau and medical advisory board for and
eceived research support from GE Healthcare. All other authors have reported that
hey have no relationships to disclose.Manuscript received July 13, 2010; revised manuscript received October 28, 2010,
ccepted November 8, 2010.obstructive CAD—as identified by CCTA and defined by
coronary plaques causing 50% reduction in luminal diam-
eter—is valuable for prognosis of individuals at risk for
incident death or major adverse cardiovascular events
(4–10).
See page 520
Nevertheless, individuals undergoing CCTA commonly
exhibit nonobstructive plaque. Prior invasive ultrasound and
autopsy studies have implicated nonobstructive plaques as
central to the pathophysiologic processes of sudden cardiac
death and myocardial infarction (11–13). Early electron
beam computed tomography (EBCT) data suggest that
3-vessel nonobstructive CAD predicts long-term mortality.
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July 26, 2011:510–9 Prognostic Value of Nonobstructive CAD by CCTAHowever, the independent predictive value of nonobstruc-
tive plaque by CCTA performed by multidetector com-
puted tomography scanners—with higher spatial resolution
to detect lower thresholds of plaque—is unknown (6).
We examined the predictive value of nonobstructive
coronary artery plaque extent and composition as detected
by 64-detector row CCTA for 3-year mortality risk among
symptomatic patients referred for suspected CAD without
prior known disease.
Methods
Patients. We evaluated consecutive adults18 years of age
etween August 2005 and December 2007 who underwent
4-detector row CCTA at 2 centers (Tennessee Heart and
ascular Institute, Hendersonville, Tennessee; Capital Car-
iology Associates, Albany, New York), which we have
reviously described (10). Institutional review board ap-
roval was obtained at each center. Patients from Tennessee
ere a distinct and nonoverlapping cohort from those
ndergoing 16-slice CCTA, which we have previously
escribed (4). Patients were referred for evaluation by
CTA for chest pain of varying degrees of typicality; a
inority of asymptomatic patients was referred for evalua-
ion of CAD in the setting of peripheral arterial disease,
erebrovascular disease, or multiple CAD risk factors. In-
ividuals with known CAD, including prior coronary re-
ascularization, and individuals with obstructive plaque by
CTA, as defined by 50% stenosis or greater, were excluded
rom the study analysis.
All patients were in normal sinus rhythm and were
apable of the breath-hold needed for CCTA. Patients with
eart rates 70 beats/min were given 5 mg intravenous
etoprolol at 5-min intervals to a total dose of 25 mg. If the
eart rate of the patient did not drop below 70 beats/min,
CTA was performed at the lowest heart rate.
Before the initiation of the scan, 2 investigators (T.C.,
.D.) prospectively collected information on the presence of
ategorical cardiac risk factors in each individual. Systemic
rterial hypertension was defined as a documented history of
igh blood pressure or treatment with antihypertensive
edications. Diabetes mellitus was defined by diagnosis of
iabetes made previously by a physician and/or use of
nsulin or oral hypoglycemic agents. Dyslipidemia was
efined as known but untreated dyslipidemia or current
reatment with lipid-lowering medications. A positive
moking history was defined as current smoking or cessation
f smoking within 3 months of testing. Family history of
oronary heart disease was determined by patient query.
en-year risk of hard coronary heart disease events were
alculated with a modified Framingham risk score, as we
ave previously described (14).
can protocol and image reconstruction. All scans were
erformed with a 64-detector row computed tomography
canner (Lightspeed VCT, GE Healthcare, Milwaukee,
isconsin). Imaging of a test-bolus of contrast was per-
ormed at 2 mm superior to the take-off of the left main poronary artery for precise timing
f contrast injection. During the
CTA acquisition, 100 cc of
odinated contrast (Isovue 370,
racco Diagnostics, Princeton,
ew Jersey, or Visipaque, GE
ealthcare, Princeton, New Jer-
ey) was injected, followed by a
0-cc saline flush. The scan pa-
ameters were: 64  0.625 mm
ollimation, tube voltage 120
V, effective 400 to 650 mA.
or radiation-sparing purposes,
oronary artery calcium scores
CACS) were not performed. Es-
imated radiation doses ranged
rom 3 to 18 mSv.
Helical or axial scan data were
btained with retrospective or prospective electrocardiogra-
hy gating, respectively. Images were reconstructed with
.625-mm slice thickness immediately after completion of
he scan to identify motion-free coronary artery images.
lectrocardiographically gated datasets were reconstructed
t 70%, 75%, and 80% of the cardiac cycle after the QRS
omplex to identify ventricular diastole, with additional
atasets reconstructed at 40%, 45%, and 50% of the cardiac
ycle to identify early diastole if necessary. For CCTA with
uboptimal image quality, multisegment reconstruction al-
orithms were employed (15). Optimal phase reconstruc-
ion was assessed by comparison of different phases, if
vailable, and the phase with the least amount of coronary
rtery motion was chosen for analysis. Multiple phases were
sed for image interpretation, if minimal coronary artery
otion was different for different arteries. The CCTAs
ere evaluated on 2-dimensional maximum intensity pro-
ections in oblique views that focused on coronary arterial
egments for optimal viewing. Two orthogonal thin maxi-
al intensity projection views approximating traditional
oronary angiography angles were used for the left anterior
escending, left circumflex, and right coronary artery circu-
ations, respectively. Three-dimensional rotation was per-
ormed, when necessary, to focus on diagonal and marginal
ranch vessels.
Three-dimensional views with curved multiplanar refor-
ation and short-axis cross-sectional viewing techniques
ere additionally used to enhance detection of obstructive
oronary plaque, if necessary. In all individuals, irrespective
f image quality, every arterial segment was scored in an
ntent-to-diagnose fashion. If a coronary artery segment was
ot interpretable, despite these multiple techniques, the
nevaluable segment was scored similarly to the most
roximal segment that was evaluable.
oronary artery analysis. All scans were analyzed by Level
II experienced cardiologists with experience interpreting
everal thousand CCTA scans (T.C., A.D.). Coronary
egments were visually scored for the presence of coronary
Abbreviations
and Acronyms
CACS  coronary artery
calcium score
CAD  coronary artery
disease
CCTA  coronary
computed tomographic
angiography
CI  confidence interval
EBCT  electron beam
computed tomography
HU  Hounsfield unit
ICA  invasive coronary
angiography
IQR  interquartile rangelaque with a 16-segment coronary artery model (left main
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Prognostic Value of Nonobstructive CAD by CCTA July 26, 2011:510–9artery; proximal, mid, and distal left anterior descending
artery; proximal, mid, and distal diagonal/intermediate
branch; proximal, mid, and distal left circumflex artery;
proximal, mid, and distal obtuse marginal branch; proximal,
mid, and distal right coronary artery) and were included for
analysis. In cases where multiple diagonal or obtuse mar-
ginal branches were present, plaques were graded with the
branch with the largest luminal diameter and/or the largest
area of myocardium subtended.
In each coronary artery segment, coronary atherosclerosis
was defined as tissue structures 1 mm3 that existed either
ithin the coronary artery lumen or adjacent to the coronary
rtery lumen that could be discriminated from surrounding
ericardial tissue, epicardial fat, or the vessel lumen itself.
oronary atherosclerotic lesions were quantified for stenosis
y visual estimation. Luminal diameter stenosis severity was
cored as none (0% luminal stenosis) or mild (1% to 49%
uminal stenosis) (Fig. 1). Percent obstruction of coronary
rtery lumen was based on a comparison of the luminal
iameter of the segment exhibiting obstruction to the
uminal diameter of the most normal-appearing site imme-
iately proximal to the plaque. In instances in which plaque
as highly calcified, 2-dimensional oblique images were also
isualized without maximal intensity projection (i.e.,
.625-mm isotropic voxel resolution) or multiplanar refor-
ats with cross-sectional views to minimize partial volume
veraging artifact of calcium.
Plaque severity was graded on a per-patient level by the
aximum intraluminal stenosis in any of the 16 scored
oronary segments. We further evaluated the plaque extent
y summing the number of epicardial vessels and the
umber of vessel segments exhibiting plaque (maximum 3
nd 16, respectively). Left main plaque was included within
he left anterior descending distribution.
Plaque composition for each coronary segment was clas-
ified as noncalcified, calcified, or mixed, as we have
reviously described (20). The optimal image display setting
Figure 1 CCTA Evaluation of CAD
Example of (A) a patient with no evident coronary artery disease (CAD) by coronar
(B) a patient with 1% to 49% stenosis in the left anterior descending artery (LAD)as chosen individually—in general, at a window between
00 and 900 Hounsfield units (HU) and at a level between
0 and 250 HU—in keeping with our clinical practice as
ell as prior published studies (16). Because the HU
ensities of fibrous, lipoid, or thrombotic plaque are known
o overlap, these plaque types were aggregated into a
noncalcified” group, which was defined as any plaque 70%
r more of which exhibited HU densities below the luminal
ontrast density (16). Calcified plaque was defined as any
laque 70% or more of which exhibited a HU density above
he luminal contrast density and at least 130 HU. “Mixed”
laque was designated as plaque that possessed 30% to 70%
alcified and noncalcified plaque volume.
ollow-up. The primary endpoint was time to death from
ll causes. Follow-up procedures were approved by the
nstitutional review board of the study center. Death status
as ascertained by querying the Social Security Death
ndex. To account for acute events in which nonobstructive
AD might have represented unstable lesions, all mortality
nalyses were performed censoring early events within the
rst 90 days after CCTA testing (4 deaths).
tatistical analysis. The SPSS software (version 12.0,
PSS, Chicago, Illinois) and SAS software (version 9.2,
AS, Cary, North Carolina) were used for all statistical
nalyses. Categorical variables are presented as frequencies,
nd continuous variables are presented as mean  1 SD.
ariables were compared with chi-square statistic for cate-
orical variables and by Student unpaired t test for contin-
ous variables. The impact of CCTA and clinical findings
n time to death was calculated with univariate Cox
roportional-hazards models. In each case, the proportional
azards assumption was met. Backward stepwise multivar-
ate regression was performed, accounting for significant
nteractions to determine the independent predictive value
f CCTA findings. Net reclassification improvement of
onobstructive plaque above and beyond Framingham esti-
ated risk was calculated with reclassification tables of
uted tomographic angiography (CCTA) and
TA.y comp
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July 26, 2011:510–9 Prognostic Value of Nonobstructive CAD by CCTAlogistic regression by tertiles of risk (0% to 1.4%, 1.4% to
1.8%, and 1.8%), because mean Framingham estimated
isk for this nonobstructive cohort was very low (17). A
-tailed p value 0.05 was considered statistically significant.
esults
aseline characteristics. Among 4,661 consecutive pa-
ients undergoing 64-detector row CCTA, 654 were ex-
luded for prior revascularization or known CAD, 1,201
ere excluded for CCTA-identified obstructive CAD, 142
ere excluded for nonverifiable Social Security numbers,
nd 81 were excluded for missing coronary segment data,
eaving 2,583 patients for whom comprehensive plaque
ssessment was available with a 16-segment coronary tree
odel. During a mean follow-up of 3.1 0.5 years (median
.1 years, interquartile range [IQR]: 2.8 to 3.5 years), 54
ntermediate-term (90 days) deaths were recorded
2.09%). The study cohort comprised persons of middle-age
52.7  13.9 years, 58% female) with a high prevalence of
ardiovascular risk factors (Table 1) and a wide distribution
f disease (Table 2).
laque involvement, severity, and overall burden. Within
he study cohort, over one-half of all individuals (58.5%) did
ot possess any coronary artery plaque, and 22.6% possessed
nly 1-vessel nonobstructive CAD. There were a median of
(IQR: 0 to 2) segments with plaques/patient; among
atients with plaques, there were a median of 0 (IQR: 0 to
) noncalcified, 0 (IQR: 0 to 1) mixed, and 1 (IQR: 0 to 1)
alcified segments/patient (Table 3).
The number of segments with nonobstructive plaques
as associated with age, male sex, hypertension, diabetes,
yslipidemia, and past smoking (Table 4). A 10% increase
n Framingham estimated 10-year risk was associated with
.7 more segments of nonobstructive plaque (95% confi-
ence interval [CI]: 0.63 to 0.77, p  0.001). Typicality of
ngina symptoms had no consistent association with non-
Baseline CharacteristicsTable 1 Baseline Characteristics
Overall (n  2,583)
Age (yrs) 52.7 13.9
Male 42.1%
Hypertension 52.8%
Diabetes 14.6%
Dyslipidemia 50.6%
Family history of premature
coronary artery disease
50.8%
Current smoking 27.5%
Past smoking 43.5%
Estimated 10-yr CHD risk* 11.0 8.9%
Symptoms
Typical angina 29.5%
Atypical chest pain 34.9%
Noncardiac chest pain 20.4%
No chest pain 15.2%
Values are mean  SD or %. *Congenital heart disease (CHD) risk esbstructive plaque burden (Table 4). Orognosis of individuals with no CAD versus with
onobstructive plaques. Individuals with no CCTA-
dentified coronary artery plaque had a favorable
ntermediate-term prognosis, with a mortality risk of 1.2%
ver the study period (annualized mortality rate 0.34%). A
igher risk was observed for individuals with any nonob-
tructive plaque, with a graded relationship by the num-
er of affected vessels (log-rank p  0.001) (Figs. 2 and 3,
able 5). Mortality was also related to age, diabetes,
yslipidemia, and smoking history (p  0.01 for all). Even
live (n  2,525) Dead (n  58) p Value
52.4 13.8 63.6 13.8 0.0001
42.0% 6.6% 0.49
52.6% 60.3% 0.24
14.4% 24.1% 0.04
50.9% 36.2% 0.03
50.9% 46.6 % 0.51
27.1% 44.8% 0.003
43.1% 62.1% 0.004
10.9 8.7% 18.3 13.3% 0.0001
0.74
29.6% 25.5%
34.9% 36.4%
20.3% 25.5%
15.2% 12.7%
with a modified Framingham risk score.
Per-Segment Analysis of Individuals Who Were AliveV sus Dead During the Follow-Up PeriodTable 2 Per-Se ment Analysis of Individuals Who Were AliveVersus Dead During the Follow-Up Period
Segment
Alive Dead
p Valuen % n %
Total 2,525 97.9% 58 2.3% 0.0001
LM 169 6.7% 3 5.2% 0.65
LAD
Proximal 699 27.7% 31 53.5% 0.0001
Mid 544 21.5% 30 51.7% 0.0001
Distal 57 2.3% 1 1.7% 0.79
Diagonal
Proximal 96 3.8% 2 3.5% 0.89
Mid 8 0.3% 1 1.7% 0.07
Distal 1 0.04% 0 0.0% 0.88
LCX
Proximal 201 8.0% 14 24.1% 0.0001
Mid 95 3.8% 7 12.1% 0.0013
Distal 13 0.5% 0 0.0% 0.58
OM
Proximal 35 1.4% 0 0.0% 0.37
Mid 16 0.6% 2 3.5% 0.01
Distal 3 0.1% 0 0.0% 0.8
RCA
Proximal 252 10.0% 14 24.1% 0.0005
Mid 220 8.7% 15 25.9% 0.0001
Distal 43 1.7% 1 1.7% 0.99ALAD left anterior descending coronary artery; LCX left circumflex artery; LM left main artery;
M  obtuse marginal artery; RCA  right coronary artery.
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risk, the presence of nonobstructive plaque conferred an
increased intermediate-term mortality risk (3.4%, log-rank
p  0.0001) (Fig. 4). Similarly, among patients with no
medically treatable risk factors—including diabetes, dyslip-
idemia, and hypertension—the presence of any nonobstruc-
tive plaque conferred an increased probability of death over
the study follow-up period (6.7%, log-rank p  0.0001)
(Fig. 5).
The number of involved segments had a nonlinear rela-
tionship with intermediate-term mortality, with an increase
in risk for those with5 segments of 9.4% (p 0.03) (Fig. 6).
As compared with individuals with 5 segments with
nonobstructive plaque, individuals possessing 5 segments
with involved plaque experienced increased intermediate-
term mortality hazard even after adjustment for CAD risk
factors (hazard ratio: 5.12, 95% CI: 2.16 to 12.10, p 
0.0002) or Framingham risk score (hazard ratio: 7.10, 95%
CI: 2.88 to 17.50, p  0.0001).
Compared with estimated Framingham risk, the presence
of any plaque showed an improved net reclassification
improvement (20.5%, p  0.04) for prediction of all-cause
death over the follow-up period. Sensitivity analyses were
Clinical Predictors of Nonobstructive Plaque ExtTable 4 Clinical Predictors of Nonobstructiv
Univariate
(95%
Age (per decade) 0.43 (0.39
Male 0.32 (0.10
Hypertension 0.48 (0.35
Diabetes 0.63 (0.46
Dyslipidemia 0.53 (0.41
Family history of coronary artery disease 0.10 (0.2
Current smoking 0.05 (0.1
Past smoking 0.33 (0.21
Framingham 10-yr risk (per 10%) 0.70 (0.63
Symptoms (compared with asymptomatic)
Typical angina 0.03 (0.0
Atypical chest pain 0.02 (0.0
Noncardiac pain 0.07 (0.1
Nonobstructive Plaque CharacteristicsTable 3 Nonobstructive Plaque Characteristics
No plaque, % 58.5
Any plaque, % 41.5
By number of epicardial arteries affected, %
1 22.6
2 13.2
3 5.7
Segmental analysis (of those with plaque)
Segments with plaque, n 2 (1–3)
Segments noncalcified plaque, n 0 (0–1)
Segments mixed plaque, n 0 (0–1)
Segments calcified plaque, n 1 (0–1)
Values are % or median (interquartile range). N  2,583.CI  confidence interval.performed for all comparisons with inclusion of events that
occurred within the first 90 days after CCTA testing and
demonstrated similar results (data not shown).
Plaque composition and plaque burden. The relationship
of plaque composition to plaque distribution is shown in
Figure 7. Patients with 5 coronary segments with
plaque—as compared with patients with 5 coronary seg-
ments with plaques—had a higher percentage of coronary
segments with calcified plaque (52% vs. 25% calcified, p 
0.001) or mixed plaque (24% vs. 13%, p  0.002), with no
difference in the percentage with noncalcified plaques (7%
vs. 13%, p  0.12). Of those with 1 to 4 involved coronary
segments, 14.4% had only mixed plaques and 14.4% had
only noncalcified plaques. In contrast, of those with 5
involved coronary segments, 12% had only mixed plaques,
and 0% had only noncalcified plaques. There was no
significant relationship between plaque composition and
intermediate-term mortality after adjustment for CAD risk
factors or presence of plaque of any type (Table 6).
Discussion
In this 2-center study of 2,583 consecutive patients without
prior known CAD and without obstructive CAD, nonob-
structive coronary artery plaque presence and extent as
identified by 64-detector row CCTA are associated with
heightened mortality risk in a 3-year follow-up period. The
CCTA nonobstructive plaque assessment added significant
risk prediction beyond patient demographic data, traditional
CAD risk factors, and Framingham risk score.
The results of the present study suggest a potential utility
for diagnosis of nonobstructive CAD by CCTA. Such
patients experience heightened mortality risk, even though
they represent a patient population for whom functional
stress testing would be expected to be negative and who
might not be referred for evaluation by invasive coronary
angiography (ICA) after CCTA. Our results confirm prior
observations of a high negative predictive value of a normal
nd Burdenque Extent and Burden
crease in Number of Affected Segments
se
p Value
Multivariate Increase
(95% CI) p Value
) 0.001 0.44 (0.40 to 0.48) 0.001
) 0.001 0.53 (0.41 to 0.64) 0.001
) 0.001 0.12 (0.004 to 0.24) 0.04
) 0.001 0.37 (0.21 to 0.53) 0.001
) 0.001 0.19 (0.07 to 0.30) 0.001
02) 0.11
08) 0.45
) 0.001 0.43 (0.32 to 0.54) 0.001
) 0.001 N/A N/A
03) 0.30
11) 0.76
28) 0.55ent ae Pla
In
Increa
CI)
to 0.47
to 0.44
to 0.60
to 0.80
to 0.65
2 to 0.
9 to 0.
to 0.45
to 0.77
9 to 0.
8 to 0.
5 to 0.
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July 26, 2011:510–9 Prognostic Value of Nonobstructive CAD by CCTACCTA for later adverse clinical events but are additive to
the prior published reports by identifying a distinction in
mortality risk for individuals with CCTAs demonstrating
no plaque versus nonobstructive plaque (4,5,18). Because
CCTA-visualized nonobstructive plaques precede the ma-
jority of deaths in this cohort, congruent to prior observa-
tions from invasive angiography, their population impact is
great despite their lower risk profile relative to obstructive
plaque.
Figure 2 Prognosis of Nonobstructive CAD
Unadjusted all-cause 3-year Kaplan-Meier survival by the absence of coronary arte
Figure 3 Prognosis of Nonobstructive CAD Burden
Unadjusted all-cause 3-year Kaplan-Meier survival by the absence of coronary arte
in 1, 2, or 3 major epicardial coronary arteries.Importantly, mortality is increased even among patients
in whom medical therapy for primary prevention of CAD
would not have been warranted. The 3-year mortality for
CCTA-visualized plaque among patients with low Fra-
mingham risk score and absence of medically treatable risk
factors of 3.7% and 6.6%, respectively, might be sufficiently
elevated to merit risk reduction by medical therapy over the
longer term. Additionally, a graded, nonlinear increase in
risk of mortality was observed with increasing plaque extent
ase (CAD) versus presence of nonobstructive CAD.
ase (CAD) versus nonobstructive CADry disery dise
516 Lin et al. JACC Vol. 58, No. 5, 2011
Prognostic Value of Nonobstructive CAD by CCTA July 26, 2011:510–9and burden, raising the question of the appropriate thresh-
old for consideration of medical therapy. Future controlled
studies should be performed to test these hypotheses.
The prognostic outcome of nonobstructive coronary plaque
by CCTA has not been well-characterized to date. Cross-
sectional studies using ICA, intravascular ultrasound, and
histopathology have long suggested the important role of
nonobstructive “vulnerable” plaques as precedents of later
myocardial infarction, but their prognostic impact with hard
events has not been characterized in longitudinal studies—due,
in part, to their invasive nature (11–13). Among asymptomatic
patients, the prognostic impact of subclinical coronary athero-
sclerosis with noncontrast-enhanced CACS has been well-
established (19). Among symptomatic patients, although the
diagnostic accuracy and prognostic impact of CCTA-
visualized obstructive CAD has been well studied, there has
been a relative neglect of nonobstructive CAD, leaving a wide
range of ambiguity for the prognosis of mild and moderate
intraluminal lesions (2,4,6). Most prognostic studies of ICA
Prognostic Value of Nonobstructive Plaque Characteristics for InteTable 5 Prognostic Value of Nonobstructive Plaque Characteris
Unadjusted HR
(95% CI) p Valu
Any plaque 3.45 (1.92–6.19) 0.001
By number of epicardial arteries affected
1 2.15 (1.03–4.46) 0.04
2 3.70 (1.78–7.70) 0.000
3 8.29 (3.92–17.54) 0.000
By number of segments
1–4 2.88 (1.54–5.39) 0.001
5 10.08 (4.62–21.97) 0.000
CAD  coronary artery disease; CI  confidence interval; FRS  Framingham risk score.
Figure 4 Prognosis of Nonobstructive CAD in Low-Risk Patient
Unadjusted all-cause 3-year Kaplan-Meier survival by the absence of coronary arte
in patients with a 10-year Framingham estimated risk 10%.and CCTA have grouped together patients with nonobstruc-
tive plaques and completely normal coronary arteries, in part to
accommodate smaller sample sizes (5,7,20).
Ostrom et al. (6), with older-generation EBCT, identi-
fied an independent predictive value of nonobstructive
CAD in all 3 major epicardial vessels, with a risk of death
comparable to single-vessel obstructive CAD. These find-
ings were observed as independent and incremental to
traditional cardiac risk factors and CACS. The prognostic
impact of lesser degrees of plaque severity, extent, overall
burden, and composition could not be discriminated, pos-
sibly due to the technologically inferior spatial resolution of
EBCT. In contrast, we employed current-generation 64-
detector CCTA with improved spatial resolution and per-
formed more detailed segmental characterization of plaque
severity, involvement, and composition. We observed that
nonobstructive coronary artery plaque presence and extent
impart increased mortality risk, even at lower thresholds of
disease (i.e., 50% stenosis).
iate-Term (>90-Day) Mortalityfor Intermediate-Term (>90-Day) Mortality
CAD RF Adjusted HR
(95% CI) p Value
FRS Adjusted HR
(95% CI) p Value
1.98 (1.06–3.69) 0.03 2.74 (1.41–5.34) 0.003
1.43 (0.68–3.03) 0.35 1.93 (0.86–4.34) 0.11
1.96 (0.89–4.29) 0.09 2.74 (1.18–6.36) 0.02
4.75 (2.10–10.75) 0.0002 6.09 (2.61–14.22) 0.0001
1.74 (0.89–3.40) 0.10 2.47 (1.21–5.03) 0.01
5.12 (2.16–12.10) 0.0002 7.10 (2.88–17.50) 0.0001
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July 26, 2011:510–9 Prognostic Value of Nonobstructive CAD by CCTAOur study results do not solidly establish the role of
plaque composition as it relates to prognosis for individuals
with nonobstructive CAD undergoing CCTA. Although
we identified a dominance of calcified and mixed plaque
composition for individuals with greater overall CAD
Figure 5 Prognosis of Nonobstructive CAD in Patients Without
Unadjusted all-cause 3-year Kaplan-Meier survival by the absence of coronary arte
with no traditional modifiable CAD risk factors (diabetes mellitus, hypertension, dy
Figure 6 Increased Nonobstructive Plaque Burden Increases M
Nonlinear risk of incident mortality on the basis of number of coronary artery segmplaque burden (5 segments), we did not observe a rela-
tionship of these plaque composition types to incident
mortality. It remains possible that, given a high prevalence
of calcified plaque in these individuals, CACS might be
sufficient to recognize and quantify risk in this symptomatic
ifiable Risk Factors
ase (CAD) versus presence of nonobstructive CAD in patients
mia).
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ry dise
slipideortal
ents e
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Prognostic Value of Nonobstructive CAD by CCTA July 26, 2011:510–9population. We have previously noted, in distinction to this
premise, a heightened risk of global reversible myocardial
ischemia in patients with increasing segments with mixed
plaque, and mixed composition plaques have been recently
demonstrated to be additive to stenosis severity for detecting
regional myocardial hypoperfusion (21). However, these
studies were performed in more inclusive cohorts than that
within the present study, including those with obstructive
CAD or even restricted to those with obstructive CAD. In
our study, CCTA was performed as part of clinical evalu-
ation of patients with suspected CAD, and CACS was not
performed for radiation-sparing reasons. It remains a clin-
ical challenge, given that symptom presentation in our
cohort was not significantly additive for prediction of global
plaque extent and burden, to identify a priori patients who
will benefit from contrast-enhanced CCTA versus patients
for whom CACS will suffice. Future carefully designed
studies should be performed to address this issue.
It is noteworthy to emphasize that our study was a
cross-sectional sample of individuals presenting with symp-
toms suggestive of CAD, and the differential proportion of
Figure 7 CAD Burden Is Associated With Plaque Composition
Coronary artery plaque composition in patients with 1-, 2-, and 3-vessel nonobstru
Prognostic Value of Nonobstructive Plaque Characteristics for InteTable 6 Prognostic Value of Nonobstructive Plaque Characteris
By Presence
Unadjusted HR
(95% CI) p Value
CAD RF
(
Noncalcified 1.19 (0.60–2.37) 0.62 0.89
Mixed 2.59 (1.46–4.60) 0.0012 1.62
Calcified 3.13 (1.84–5.33) 0.0001 1.61Adjusted for presence of any plaque of any type.
CAD  coronary artery disease; HR  hazard ratio; RF  risk factor.calcified, mixed, and noncalcified plaques represent a single
“point-in-time” for which assertions regarding plaque pro-
gression are not possible. In our cohort, individuals with
greater extent and burden of nonobstructive plaque were
more likely to exhibit calcified and mixed plaques and less
likely to exhibit noncalcified plaques alone. Indeed, among
individuals with 5 segments with plaque, 12% exhibited
only mixed plaque type, whereas 0% exhibited only noncal-
cified plaque type. It is possible that nonobstructive, non-
calcified components of mixed plaques include a high-risk
subgroup of plaques with transformative potential to beget
incident adverse CAD events, whereas purely noncalcified
plaques are less likely to exhibit this property. Noncalcified
components of plaques as visualized by CCTA have greater
odds of disease progression on serial angiographic studies, and
the presence of nonobstructive plaques containing low-density
components, “spotty” calcifications, and positive arterial re-
modeling have been observed to predict incident acute coro-
nary syndrome (9,22,23). Future studies examining plaque
progression by CCTA will be useful to characterize further the
natural history of plaques in relation to their composition.
oronary artery disease (CAD). vd  vessel disease.
iate-Term (>90-Day) Mortalityfor Intermediate-Term (>90-Day) Mortality
sence of Plaque Composition Type
ted HR
I) p Value
Plaque-Adjusted HR
(95% CI) p Value
1.78) 0.74 0.56 (0.27–1.15) 0.12
2.94) 0.12 1.40 (0.74–2.65) 0.30
2.91) 0.12 1.75 (0.89–3.43) 0.10ctive crmedtics
or Ab
-Adjus
95% C
(0.44–
(0.89–
(0.89–
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July 26, 2011:510–9 Prognostic Value of Nonobstructive CAD by CCTAStudy limitations. This study is not without limitations.
Although the use of all-cause mortality provides a robust
endpoint free of ascertainment bias, it nevertheless limits the
risk predictive power of CCTA findings, due to the relatively
low event rate and inclusion of noncardiac deaths. Second,
treatment goals and medications were left to the discretion of
the caring physicians, and downstream patient care might have
been influenced by CCTA results in this open-label study.
Third, there might be residual or unmeasured confounding due
to health behaviors, which might account for the apparent
protective effect for mortality of dyslipidemia by either history
or treatment. Fourth, certain adverse CCTA plaque character-
istics that have been described among culprit plaques in acute
coronary syndrome–such as positive remodeling, spotty calci-
fications, low attenuation density, or finer gradations of plaque
composition–were not measured and could not be evaluated for
risk-predictive ability. Finally, this study examined individuals
referred for clinically indicated CCTA. Although we observed
inconsistent relationships among symptom typicality, plaque
burden, and mortality, the present findings should not be
generalized to asymptomatic patients, who might have disease
prevalence and outcomes that differ from our symptomatic
cohort.
Conclusions
Among individuals without known CAD and obstructive
CAD, nonobstructive plaque presence and extent as iden-
tified by 64-detector row CCTA enhances risk prediction of
incident mortality. Improved risk stratification is evident for
nonobstructive CAD, even for patients with low Framing-
ham risk scores as well as for patients without traditional
modifiable CAD risk factors for whom medical therapy for
primary prevention of CAD would not be warranted. Future
studies examining the impact of treatment of individuals
with nonobstructive CAD should be performed.
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